Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GAMES-RP: Glyburide in Severe Ischemic Stroke
NCT01794182Phase 2Completed
- Sponsor
- Remedy Pharmaceuticals
- Start
- Jun 2013
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of glibenclamide in ischemic stroke, Malignant edema (ME), sponsored by Remedy Pharmaceuticals. Started Jun 2013; status: completed.
02
Drugs
glibenclamide
03
Conditions
ischemic strokeMalignant edema (ME)
Beyond the preview
Go deeper on NCT01794182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01794182.